← SynDRA
PRIDOPIDINE
SynDRA canonical compound SYN0020483 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | DRD2 |
| Mechanism of action | dopamine receptor antagonist |
All known targets
Mechanisms of action (all sources)
- DRD2 MODULATOR
- Dopamine D2 receptor modulator
- SIGMAR1 AGONIST
- dopamine receptor antagonist
Cross-references
Synonyms
- Pridopidina
- ACR-16
- ACR16
- FR-310826
- FR310826
- Huntexil
- 4-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine
- 4-(3-(Methylsulfonyl)phenyl)-1-propylpiperidine
- ACR 16
- UNII-HD4TW8S2VK
- HD4TW8S2VK
- CHEMBL596802
- Pridopidine [USAN:INN]
- Pridopidine (USAN/INN)
- 4-(3-Methanesulfonyl-phenyl)-1-propyl-piperidine
- SCHEMBL166748
- CTK4H2809
- DTXSID90188225
- ASP-2314
- ZINC22063703
- BDBM50308028
- AKOS015891431
- DB11947
- NCGC00386586-01
- HY-10684
- AS-50146
- AJ-80925
- FR 310826
- DB-014417
- AX8258340
- CS-0002733
- FT-0672149
- Pridopidine hydrochloride
- Dopamine modulator (Huntingtons disease), Carlsson Research
- Dopamine modulator (Huntingtons disease), NeuroSearch
- Dopamine modulator (schizophrenia), Astellas
- Dopamine modulator (schizophrenia), Fujisawa
- Dopamine modulator (neurological disorders), Merck & Co
- ACR16 compound
Look up PRIDOPIDINE in the interactive SynDRA portal →